相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of Epac2A/Rap1 Signaling in Interplay Between Incretin and Sulfonylurea in Insulin Secretion
Harumi Takahashi et al.
DIABETES (2015)
Sulfonylureas: A New Look at Old Therapy
Peter M. Thule et al.
CURRENT DIABETES REPORTS (2014)
Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges
Rodolpho C. Braga et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
A review of the efficacy and safety of oral antidiabetic drugs
Stephanie Aleskow Stein et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Antidiabetic Sulfonylureas and cAMP Cooperatively Activate Epac2A
Toshimasa Takahashi et al.
SCIENCE SIGNALING (2013)
Treating diabetes today: a matter of selectivity of sulphonylureas
S. Seino et al.
DIABETES OBESITY & METABOLISM (2012)
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes
Ebenezer A. Nyenwe et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Hyperinsulinism and Diabetes: Genetic Dissection of β Cell Metabolism-Excitation Coupling in Mice
Maria Sara Remedi et al.
CELL METABOLISM (2009)
Theoretical study of molecular structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some hypoglycemic agents
Milan Remko
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM (2009)
The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs
Chang-Liang Zhang et al.
SCIENCE (2009)
Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by CAMP
Tadao Shibasaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Novel 2D fingerprints for ligand-based virtual screening
Todd Ewing et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Ewan R. Pearson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Meglitinide analogues:: a review of clinical data focused on recent trials
JF Blicklé
DIABETES & METABOLISM (2006)
ATP-sensitive potassium channelopathies: focus on insulin secretion
FM Ashcroft
JOURNAL OF CLINICAL INVESTIGATION (2005)
Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility
T Miki et al.
DIABETES (2005)
Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity
K Nagashima et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
Physiological and pathophysiological roles of ATP-sensitive K+ channels
S Seino et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2003)
Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action
E Renström et al.
DIABETES (2002)
The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion:: comparison with the sulfonylureas and nateglinide
Y Sunaga et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Triggering and amplifying pathways of regulation of insulin secretion by glucose
JC Henquin
DIABETES (2000)
Improving drug solubility for oral delivery using solid dispersions
C Leuner et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
分享论文
